The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

For patients with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM), screening for pathogenic variants has become standard clinical practice. Genetic cascade screening also allows the identification of relatives that carry the same mutation as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stege, Nienke M., de Boer, Rudolf A., van den Berg, Maarten P., Silljé, Herman H. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998409/
https://www.ncbi.nlm.nih.gov/pubmed/33799487
http://dx.doi.org/10.3390/ijms22062955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998409/
https://www.ncbi.nlm.nih.gov/pubmed/33799487
http://dx.doi.org/10.3390/ijms22062955

Ejemplares similares